LGALS3 and aortic stenosis: Furthermore, in patients with aortic stenosis and concomitant diabetes, galectin-3 levels were associated with systemic proinflammatory and profibrotic responses, myocardial remodeling, and adverse clinical outcomes, emphasizing its involvement in the pathogenesis of diastolic dysfunction in this high-risk population [10].